RSS Feed Print
FDA approves first drug intended to slow cognitive decline caused by Alzheimer’s disease
MPSunshine
Posted: Monday, June 7, 2021 3:50 PM
Joined: 5/21/2016
Posts: 2011


From today’s The Washington Post, aducanumab is intended to slow cognitive decline. More details about this controversial drug and decision within the article. https://www.washingtonpost.com/health/2021/06/07/fda-approves-alzheimers-drug-aducanumab/
Marp
Posted: Sunday, June 13, 2021 7:26 AM
Joined: 2/7/2012
Posts: 74


I'm concerned about the incidence of amyloid-related imaging abnormalities that I've read can occur as much as 40% of the time.  Many are asymptomatic, but that mean it's okay?

https://memory.ucsf.edu/aducanumab

 

https://memory.ucsf.edu/aducanumab#:~:text=About%204%20in%2010%20patients,a%20combination%20of%20the%20two

 


HeartOnSleeve2210
Posted: Friday, September 24, 2021 9:53 PM
Joined: 9/8/2021
Posts: 18


I looked up on that as a possible medication to bring up to my Grandfather's PCP, but then I saw the side effects. The medication can cause brain swelling and brain bleeds. That's far too big of a risk to take in my opinion. To me, the risks seem to outweigh the benefits, and it makes me quite nervous.